<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">RUDN Journal of Medicine</journal-id><journal-title-group><journal-title xml:lang="en">RUDN Journal of Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российского университета дружбы народов. Серия: Медицина</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-0245</issn><issn publication-format="electronic">2313-0261</issn><publisher><publisher-name xml:lang="en">Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">25437</article-id><article-id pub-id-type="doi">10.22363/2313-0245-2021-25-1-48-54</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL AND EXPERIMENTAL PHYSIOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНАЯ И КЛИНИЧЕСКАЯ ФИЗИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Assessment of the role of IL6 and IL10 gene polymorphisms as a risk factor for the development of restenosis in patients after implantation of drug-eluting stents</article-title><trans-title-group xml:lang="ru"><trans-title>Оценка роли полиморфных вариантов генов IL6 и IL10 как фактора риска развития рестеноза у пациентов после имплантации стентов с лекарственным покрытием</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Timizheva</surname><given-names>K. B.</given-names></name><name xml:lang="ru"><surname>Тимижева</surname><given-names>К. Б.</given-names></name></name-alternatives><email>kalima.bogatyreva@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Aghajanyan</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Агаджанян</surname><given-names>А. В.</given-names></name></name-alternatives><email>kalima.bogatyreva@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tskhovrebova</surname><given-names>L. V.</given-names></name><name xml:lang="ru"><surname>Цховребова</surname><given-names>Л. В.</given-names></name></name-alternatives><email>kalima.bogatyreva@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shugushev</surname><given-names>Z. Kh.</given-names></name><name xml:lang="ru"><surname>Шугушев</surname><given-names>З. Х.</given-names></name></name-alternatives><email>kalima.bogatyreva@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Azova</surname><given-names>M. M.</given-names></name><name xml:lang="ru"><surname>Азова</surname><given-names>М. М.</given-names></name></name-alternatives><email>kalima.bogatyreva@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Peoples’ Friendship University of Russia (RUDN University)</institution></aff><aff><institution xml:lang="ru">Российский университет дружбы народов</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Federal Research and Clinical Center of Physical-Chemical Medicine</institution></aff><aff><institution xml:lang="ru">Федеральный научно-клинический центр физико-химической медицины</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Central clinical hospital «RZD-Medicine»</institution></aff><aff><institution xml:lang="ru">Центральная клиническая больница № 2 им. Н.А. Семашко ОАО «РЖД»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-01-12" publication-format="electronic"><day>12</day><month>01</month><year>2021</year></pub-date><volume>25</volume><issue>1</issue><issue-title xml:lang="en">CORONAVIRUS INFECTION, INFECTIOUS DISEASES</issue-title><issue-title xml:lang="ru">КОРОНАВИРУСНАЯ ИНФЕКЦИЯ, ИНФЕКЦИОННЫЕ БОЛЕЗНИ</issue-title><fpage>48</fpage><lpage>54</lpage><history><date date-type="received" iso-8601-date="2021-01-12"><day>12</day><month>01</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Timizheva K.B., Aghajanyan A.V., Tskhovrebova L.V., Shugushev Z.K., Azova M.M.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Тимижева К.Б., Агаджанян А.В., Цховребова Л.В., Шугушев З.Х., Азова М.М.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Timizheva K.B., Aghajanyan A.V., Tskhovrebova L.V., Shugushev Z.K., Azova M.M.</copyright-holder><copyright-holder xml:lang="ru">Тимижева К.Б., Агаджанян А.В., Цховребова Л.В., Шугушев З.Х., Азова М.М.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.rudn.ru/medicine/article/view/25437">https://journals.rudn.ru/medicine/article/view/25437</self-uri><abstract xml:lang="en"><p>Relevance. Currently, the number of percutaneous coronary interventions continues to increase, which leads to an increase in the absolute number of restenosis cases, which is the main complication of the long-term postoperative period. The search for risk factors responsible for restenosis and artery re-narrowing mechanisms in order to prevent this complication is an important goal in interventional cardiology. Risk factors for the restenosis development include clinical, angiographic and genetic factors. An active search for biomolecular markers associated with the coronary artery restenosis is currently underway. Objective: to study the role of polymorphic variants C-174G of the IL6 gene and C-819T of the IL10 gene as a risk factor for the development of restenosis in patients after stent implantation. Materials and Methods : The study included 113 patients with stable coronary artery disease, who had previously undergone balloon angioplasty and implantation of drug-eluting stents, and 62 patients with intact arteries that were included to the control group. Statistical data processing was carried out using the R-language program and the SPSS Statistics 20 software package. Results: GG genotype for IL6 gene was associated with the development of coronary artery disease. In the subgroup of patients over 65 years of age and instent restenosis, the GG genotype was significantly less frequent. The homozygous CC genotype for IL10 gene was associated with rapid angiographic in-stent restenosis progression.</p></abstract><trans-abstract xml:lang="ru"><p>Актуальность . В настоящее время наблюдается увеличение количества чрескожных коронарных вмешательств, что приводит к росту абсолютного числа случаев рестеноза, основного осложнения, развивающегося в отдаленном послеоперационном периоде. Поиск факторов риска рестенозирования стентов и определение механизмов развития повторного сужения артерий с целью профилактики данного осложнения является актуальной задачей в интервенционной кардиологии. К факторам риска развития рестеноза относят клинические, ангиографические и генетические факторы. В настоящее время проводится активный поиск биомолекулярных маркеров, ассоциированных с развитием рестеноза коронарных артерий. Цель : исследование роли полиморфных вариантов C-174G гена IL6 и C-819T гена IL10 как фактора риска развития рестеноза у пациентов после стентирования коронарных артерий. Материалы и методы: в исследовании принимали участие 113 пациентов со стабильной формой ишемической болезни сердца, которым ранее проводились баллонная ангиопластика и имплантация стентов с лекарственным покрытием и 62 пациента с интактными артериями, включенных в контрольную группу. Статистическая обработка данных проводилась с помощью программы R-language и пакета программного обеспечения SPSS Statistics 20. Результаты . Были выявлены статистически достоверные отличия по полиморфизму гена IL6 между пациентами с ИБС и контрольной группой. Обнаружена ассоциация генотипа GG по гену IL6 с развитием ИБС. В подгруппе пациентов старше 65 лет и рестенозом генотип GG встречается достоверно реже. Гомозиготный генотип СС по гену IL10 ассоциирован с ранним развитием рестеноза внутри стентов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>in-stent restenosis</kwd><kwd>IL6</kwd><kwd>IL10</kwd><kwd>gene polymorphisms</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>IL6</kwd><kwd>IL10</kwd><kwd>рестеноз внутри стента</kwd><kwd>генные полиморфизмы</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Scientific Organizing Committee of the ESSE-RF project. Epidemiology of cardiovascular diseases in various regions of Russia (ESSE-RF). Rationale and design of the study. Preventive medicine. 2013;16(6):25-34.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Levine GN, Bates ER, Blankenship JC, et al. ACCF / AHA / SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll. Cardiol. 2011;58:P.44-122.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Roger L, Go AS, Lloyd-Jones DM., et al. Statistics. Update A Report From the American Heart Association Circulation. 2011.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Fukuda D, Shimada K, Tanaka A, Kawarabayashi T, Yoshiyama M, Yoshikawa J. Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol. 2004;43(1):18-23.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Sun J, Yu H, Liu H, Pu D, Gao., Jin X, Liu X, Yan A. Correlation of pre-operative circulating inflammatory cytokines with restenosis and rapid angiographic stenotic progression risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents. J Clin Lab Anal. 2020;34(3):e23108.</mixed-citation></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Montone R. A, Niccoli G. Predictive value of C-reactive protein after drug-eluting stent implantation: an update view. Future Cardiol. 2018;14(5):355— 358.</mixed-citation><mixed-citation xml:lang="ru">Montone R. A, Niccoli G. Predictive value of C-reactive protein after drug-eluting stent implantation: an update view. Future Cardiol. 2018;14(5):355—358.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><mixed-citation>Zurakowski A, Wojakowski W, Dzielski T, Milewski K, GościńskaBis K, Tendera M, Buszman P. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting. Kardiol Pol. 2009;67(6):623-30.</mixed-citation></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Kazmierczak E, Grajek S, Kowal J, Chmara E, Grygier M, Pyda M, et al. Prognostic usefulness of IL-6 and VEGF for the occurrence of changes in coronary arteries of patients with stable angina and implanted stents. Eur Rev Med Pharmacol Sci. 2014;18(15):2169-75.</mixed-citation><mixed-citation xml:lang="ru">Kazmierczak E, Grajek S, Kowal J, Chmara E, Grygier M, Pyda M, et al. Prognostic usefulness of IL-6 and VEGF for the occurrence of changes in coronary arteries of patients with stable angina and implanted stents. Eur Rev Med Pharmacol Sci. 2014;18(15):216975.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><mixed-citation>Kumari R, Kumar S, Ahmad MK, Singh R, Kant Kumar S, Pradhan A, Chandra S, Kumar S. Promoter variants of TNF-α rs1800629 and IL-10 rs1800871 are independently associated with the susceptibility of coronary artery disease in north Indian. Cytokine. 2018;110:131-136.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Yu GI, Cho HC, Cho YK, Park HS, Yoon HJ, Kim HS, et al. Association of promoter region single nucleotide polymorphisms at positions -819C/T and -592C/A of interleukin 10 gene with ischemic heart disease. Inflamm Res. 2012;61(8):899-905.</mixed-citation></ref></ref-list></back></article>
